Infantile mesenchymal hamartoma of the liver with elevated alpha fetoprotein

Liem Thanh Le1, Hai Thanh Phan1, Trung Sao Nguyen1

  • 1Medic Medical Center, Ho Chi Minh, Vietnam.

BJR Case Reports
|June 16, 2021
PubMed

Insights

Mesenchymal hamartoma of the liver (MHL), a benign pediatric tumor, can present with unusually high alpha-fetoprotein (AFP) levels, mimicking malignancy. This case highlights the diagnostic challenge of MHL with atypical AFP elevation.

Area of Science:

  • Pediatric Oncology
  • Hepatobiliary Pathology
  • Diagnostic Imaging

Background:

  • Mesenchymal hamartoma of the liver (MHL) is a rare, benign liver tumor predominantly seen in infants and young children.
  • Elevated alpha-fetoprotein (AFP) levels are typically associated with malignant liver tumors like hepatoblastoma, posing a diagnostic challenge in differentiating benign conditions.

Observation:

  • A 3-month-old infant presented with an incidentally detected liver mass and markedly elevated serum AFP levels (6388.4 ng/mL).
  • Initial imaging (ultrasound and MRI) suggested mesenchymal hepatic sarcoma, a malignant diagnosis.
  • Surgical resection of the liver segment containing the tumor was performed.

Findings:

  • Post-operative histopathological examination confirmed the diagnosis of MHL, not mesenchymal hepatic sarcoma.
  • Serum AFP levels rapidly normalized after surgical removal of the MHL.
  • This case demonstrates an atypical presentation of MHL with significantly elevated AFP.

Implications:

  • MHL should be considered in the differential diagnosis of pediatric liver masses with elevated AFP, even when levels are very high.
  • Atypical presentations of MHL can lead to misdiagnosis and delayed treatment if not carefully evaluated.
  • Accurate histopathological examination is crucial for definitive diagnosis and appropriate management of pediatric liver tumors.

Related Concept Videos